Table 4: Effect of oral administration of bLF on patients in test group after 3 months (results represented as mean ± SD values).

ParameterControl
mean ± SD
LF
mean ± SD

BUN (mg/dL)0.3 ± 2.94.8 ± 3.14*
Serum creatinine (mg/dL)0.078 ± 0.220.14 ± 0.26*
AST (IU/L)0.306 ± 7.2912.44 ± 13.22*
ALT (IU/L)0.88 ± 5.46.88 ± 11.27*
Serum LF (ng/mL)0.002 ± 0.011 0.15 ± 0.16*
Serum GST enzyme (ng/mL)0.000 ± 0.0020.206 ± 0.089*
INF-γ (pg/mL)0.1 ± 0.271.62 ± 0.66*
WBCs (*103 cell/µL)0.146 ± 0.7271.06 ± 1.18*
Platelet (*103/mm3)25.40 ± 39.0636.46 ± 12.26*
CEA (ng/mL)8.37 ± 23.9113.41 ± 21.91*
RBCs (*106/µL)0.111 ± 0.2220.514 ± 0.126*
Neutrophil (%)0.93 ± 4.711.86 ± 1.45*
Hb (g/dL)0.52 ± 1.21.97 ± 0.35*

Note: *significant difference .